Best Astrazeneca Podcasts (2025)

1
The Future of Quality and Validation with Astrazeneca’s Bob Buhlmann 28:59

2h ago28:59

28:59

This week’s guest is Bob Buhlmann, Head of Quality Digital and Computer Strategy at AstraZeneca. Bob shares how technology has evolved over the course of his 35+ years in the pharma industry, the hurdles pharma companies often face when adopting emerging technology, and the future of quality management. He also takes a deep dive into validation, th…

1
Creating Breakthroughs in Oncology: A Conversation with Susan Galbraith of AstraZeneca 43:26

10d ago43:26

43:26

In this episode of Idea Collider, we sit down with Susan Galbraith from AstraZeneca, a leading figure in oncology R&D. Susan shares her journey from medical training in Manchester and Cambridge to spearheading transformative cancer treatments at AstraZeneca. She discusses pivotal moments in her career, AstraZeneca's vision for eliminating cancer as…

1
Counting the cost of Marks & Spencer’s cyber-attack, and AstraZeneca versus GSK 53:58

12d ago53:58

53:58

On this week’s AJ Bell Money & Markets podcast, Dan Coatsworth and Tom Sieber explore some big names on the UK and US stock market following a spate of corporate updates over the past week. They chat about Guinness maker Diageo, sausage roll giant Greggs, and a trio of American firms which have given us a fascinating insight into the state of the U…

1
Episode 186 - Transitioning into insurance from the armed forces 24:41

2h ago24:41

24:41

In this episode of the Journal podcast, Matthew Greig, Business Development Executive at the CII, and former armed forces veteran who had recently transitioned into the profession, is joined by industry leaders to explore how armed forces personnel can successfully transition into rewarding careers in insurance. The discussion highlights the pathwa…

1
Aligning AI with Business Value: People, Data and Governance 32:58

3h ago32:58

32:58

In this episode, Craig is joined by Jose Carvalho, Co-Founder and Managing Partner at the Value AI Institute and Global Head of Centre of Excellence at The Digital Economist. Together they cut through the AI buzz and Jose shares a practical roadmap for turning AI into sustainable business value. Jose also stresses why true success starts with peopl…

1
Pharma and Biotech Daily: Roche and Jazz's Promising Lung Cancer Combo, Trump's Tariffs Impact, and BioAgilytix's Drug Production Capabilities at BIO International 1:11

1h ago1:11

1:11

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche and Jazz Pharmaceuticals presented data at ASCO showing that their drug combination improved survival in a phase III lung cancer trial, with analysts noting a strong treatment effect. Jazz has filed for FDA approva…

1
Janice Stucke: Global Financial Leadership and Transforming CREW Network 42:37

10h ago42:37

42:37

What happens when an international affairs enthusiast with a passion for humanitarian aid transitions into becoming a leading financial strategist? Janice Stucke, CFO and Foundation Treasurer of CREW Network, joins us to share her unique journey from restaurateur roots to spearheading global digital transformations. On this episode of Secrets of Ro…

1
Pharma and Biotech Daily: Key Updates in the World of Pharmaceuticals and Biotechnology 1:33

12h ago1:33

1:33

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Regeneron's shares have dropped due to the failure of their dupixent follow-up drug, while Sanofi has acquired Blueprint for $9.5 billion to expand their rare disease portfolio. Bristol Myers Squibb is collaborating with …

1
Investment Trust show: AI stock picking, Fundsmith’s small cap strategy, and an alternative spin on the defence sector 1:10:16

1d ago1:10:16

1:10:16

Dan Coatsworth and Laith Khalaf bring you a bonus edition of the AJ Bell Money & Markets podcast, all about investment trusts. The pair answer your questions about trusts and talk to a range of experts about fascinating things happening on the market. Dan chats to Muzo Kayacan and David Barron from BlackRock American Income about the investment tru…

1
How Champions Are Made | Discipline, Fire, and Focus 20:30

1d ago20:30

20:30

In this episode of The Burn Podcast, Ben Newman delivers one of his most honest and soul-stirring messages yet—a no-fluff, no-hype conversation that will challenge YOU to let go of the weight of your past and step fully into the power of what YOU can control: TODAY. Ben pulls back the curtain on the mental toughness it takes to chase greatness—not …

1
Pharma and Biotech Daily: Catching up on the Latest in the Industry 0:47

1d ago0:47

0:47

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The Summit's bispecific drug missed the survival endpoint in a global Phase III trial, but analysts remain optimistic about its potential to appeal to both Eastern and Western patient populations. Sanofi and Regeneron saw…

1
Trumps pause on EU tariffs, UK growth back in the spotlight and how to prep for a meaningful retirement 1:01:59

4d ago1:01:59

1:01:59

This week on the AJ Bell Money and Markets podcast, Charlene Young and Tom Sieber unpack Trump’s latest tariff U-turn [02:10] and UK growth forecasts from the IMF that also came with a warning for the Chancellor about her fiscal rules [04:25]. The energy price cap is falling and the Prime Minister says he wants more people to get the winter fuel pa…

1
Pharma and Biotech Daily: Top News in Gene Therapy, Vaccine Contracts, and Industry Updates 0:51

5d ago0:51

0:51

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Intellia reported an adverse event in its gene therapy trial, causing its stock to drop, adding to existing safety concerns in gene therapy. Analysts downplayed the event, but patient deaths in other trials have raised…

1
Pharma and Biotech Daily: Insider Trading, R&D Spending, and Acquisitions in the World of Pharmaceuticals 1:59

6d ago1:59

1:59

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former Chinook board member, Rouzbeh Haghighat, has been indicted for insider trading related to Novartis' $3.2 billion acquisition of the company. Despite this scandal, pharma R&D spending increased in 2024, climbing 1.5…

1
Pharma and Biotech Daily: Navigating the Complexities of mRNA Technology and Gene Therapies 1:42

7d ago1:42

1:42

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.A patient death has led to the halt of Rocket's gene therapy trial for Danon disease, due to complications from an acute systemic infection. This incident highlights the unpredictable nature of gene therapies and may pose…

1
Building a Two-Sided Marketplace: The Paro Story with Michael Burdick 35:23

7d ago35:23

35:23

The world of finance and accounting is undergoing a rapid transformation, driven by technology and innovative business models. In this episode, Michael Burdick, founder and CFO of Paro, shares his insights on the evolving landscape of finance and accounting solutions. He discusses the vision behind Paro.ai, a two-sided marketplace empowering financ…

1
Street Smarts to Shark Tank | Daymond John's Journey from Hustle to Icon 24:58

7d ago24:58

24:58

In this powerful episode of The Burn Podcast, we’re joined by none other than Daymond John—iconic entrepreneur, branding expert, and one of the original Sharks from the 4-time Emmy Award-winning Shark Tank. From humble beginnings in Queens, New York, to building the global fashion empire FUBU with just $40, Daymond’s story is a testament to resilie…

1
Pharma and Biotech Daily: Navigating Turbulent Times in the Biopharma Industry 0:50

8d ago0:50

0:50

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The biopharma industry is currently facing challenges such as tariff threats and regulatory upheaval. The market has been described as 'moribund' with the need for companies to survive in these tough times. Recent top st…

1
Pharma and Biotech Daily: Your Daily Dose of What Matters in the Industry 1:07

9d ago1:07

1:07

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.A court has halted the Trump administration's plans to reduce and lay off employees in government agencies, citing a lack of authority. Meanwhile, a report called "Make American Healthy Again" criticizes pharmaceutical lobb…

1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates 0:58

12d ago0:58

0:58

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sanofi has acquired Vigil for $470 million upfront, sparking interest in the Alzheimer's target Trem2 following previous failures. The FDA is encouraging states to import drugs from Canada to alleviate drug shortages. In o…

1
How data spaces can improve global supply chains ? - with Carlos Mendez, Innovation Technology Manager 6:00

12d ago6:00

6:00

Data spaces hold great potential for the way that public and private data is used and shared – and can help drive social and economic innovation. They can bring benefits not just commercially but for global security, for the benefit of the environment, and for the health of our populations. In this episode, Carlos Mendez, Innovation Technology M…

1
Survival Strategies and Strategic Partnerships: The Latest in Pharma and Biotech 1:45

13d ago1:45

1:45

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Moderna has withdrawn its application for a combination flu and COVID-19 vaccine after discussions with the FDA. The vaccine had shown efficacy in eliciting antibodies, but the company decided to pull the application. In …

1
The Rise of the Frontline Engineer: Driving Digital Transformation on the Shop Floor 34:49

13d ago34:49

34:49

This week’s guests are Ryan Infantozi of VEKA, Esmeralda Gonzalez of Stanley Black & Decker, and Cuyler Monahan of Agility EMS. The three represent a new generation of frontline engineers—dedicated shop floor problem solvers applying digital technology to tackle the diverse set of challenges each of their operations face on a daily basis. The three…

1
Episode 185 - Health & Wellbeing Podcast 41:13

13d ago41:13

41:13

In this episode of the podcast we are joined by Anna Reddy, Founder of Leap Health, a provider of bespoke, innovative and simple corporate wellbeing & wellness solutions. We discuss the impact of health and wellbeing in the workplace and tips on how to improve your physical and mental health. Resources: https://leaphealth.co.uk/resources/https://ww…

1
Shaping BTP: SAP’s BTP Voice of the Customer Programme 36:30

14d ago36:30

36:30

In this episode of SUGTalks, Craig Dale is joined by Stefan Kneis, Chief Customer Officer and Head of BTP Product Success at SAP. They explore the launch of SAP’s new Voice of the Customer programme for BTP, designed to gather meaningful user input at scale and shape future product direction. Stefan shares how feedback has already influenced BTP’s …

1
Pharma and Biotech Daily: Pfizer's $6 Billion Bet, CRISPR Baby Success, and Bio-Rad's Antibody Discovery Platform 1:10

14d ago1:10

1:10

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer has made a $6 billion bet on acquiring 3SBio's PD-1/VEGF antibody, despite being a late entrant to the space. This deal comes after Pfizer's partnership with Summit Therapeutics, causing some confusion about the p…

1
More Than Numbers: Melissa Hurrington's Holistic Approach to Life and Leadership 50:46

14d ago50:46

50:46

Being a CFO is more than just crunching numbers. In this episode of Secrets of Rockstar CFOs, Melissa Hurrington, CFO and VP of Operations at Premier Claims, shares her insights on a holistic approach to life and leadership. Melissa discusses her multifaceted role as a CFO, wife, mother, servant leader, keynote speaker, lifelong learner, and passio…

1
Pharma and Biotech Daily: Navigating the Latest Industry News and Challenges 1:45

15d ago1:45

1:45

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Regeneron has acquired ownership of 23andme for $256 million, promising to comply with consumer privacy policies. Makary's proposed rare disease pathway has sparked hope but raised questions among experts. At the American…

1
Live Like It’s YOUR Last Day: Ashwin Mohan on Purpose, Discipline, and Daily Consistency 29:37

15d ago29:37

29:37

In this episode of The Burn Podcast, we welcome back Ashwin Mohan—founder of Mohan Coaching and one of the top-ranked advisors in the country. Ranked #8 out of more than 10,000 career advisors in financial security planning at a Fortune 100 company, Ashwin exemplifies purpose-driven leadership, relentless discipline, and elite execution. Ashwin div…

1
Novo Nordisk CEO Lars Fruergaard Jorgensen to Depart Amid Share Decline: Pharma and Biotech Daily Update 0:32

16d ago0:32

0:32

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Novo Nordisk CEO Lars Fruergaard Jorgensen is set to depart as the Danish pharma company's shares have been on a decline. During Jorgensen's eight-year tenure, the company saw significant growth in sales, profits, and shar…

1
Biotech Innovations & Leadership with John Maraganore 39:02

17d ago39:02

39:02

In this episode of IDEA Collider, we dive into the world of biotech innovation with John Maraganore, former CEO of Alnylam Pharmaceuticals. Recognized as a trailblazer, John transformed RNA interference from a scientific concept into a revolutionary class of medicines, leading the development of five life-changing drugs. Join us as we explore John'…

1
Pharma and Biotech Daily: Senate Hearings, Accelerated Approvals, and Big Investments 1:13

19d ago1:13

1:13

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.At a recent U.S. Senate hearing, Health and Human Services Secretary was questioned about cuts being made to the department and his stance on endorsing the measles vaccine during a growing outbreak. The hearing was tense at…

1
Trade deals, rate cuts and filling Warren Buffett’s shoes 53:12

19d ago53:12

53:12

On this week’s episode of the AJ Bell Money and Markets podcast Danni Hewson and Charlene Young take stock of which trade deals have been struck in the wake of Donald Trump’s tariff policies and assess how markets and some of those big US stocks like Nvidia have performed.[2:09] A week after the Bank of England cut its base rates they consider wher…

1
Pharma and Biotech Daily: Breaking News and Innovations in Healthcare 2:31

20d ago2:31

2:31

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination of drugs that has shown promising results in treating pancreatic cancer. Th…

1
Pharma and Biotech Daily: Restructuring, Innovation Opportunities, and Industry Updates 1:10

21d ago1:10

1:10

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Bayer has announced a restructuring that will result in 2,000 job cuts and a reduction in management layers. CEO Bill Anderson believes Trump's most favored nations policy could provide an opportunity for European countries…

1
Ask the Experts: Empowering Women Through Health Education—Addressing Obesity 58:16

21d ago58:16

58:16

Audience called in and asked questions of our experts for Women's Health Month about the many factors contributing to obesity and how you can make healthier steps to create a lasting impact on overall wellness. Find more helpful resources at diabetes.org/Obesity.

1
CFO Career Paths: Finding Your Value and Embracing the Journey with Denise W. Marks 37:17

21d ago37:17

37:17

There are many ways to add value and have an amazing career as a CFO. In this episode, Denise W. Marks, CFO of the CareQuest Institute for Oral Health, shares her insights on navigating a successful career path in finance. Denise discusses the importance of embracing diverse opportunities, not being afraid to ask for help, and finding your own uniq…

1
Pharma and Biotech Daily Podcast: Stay Informed on Drug Pricing, HIV Research, and Industry Updates 2:09

22d ago2:09

2:09

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The White House has announced a new drug pricing policy that includes the revival of the most favored nations rule and extends to the private markets, leveraging the patent system, drug importation, and more. Meanwhile, L…

1
No Excuses, Just Execution | Molly Fletcher on Winning in a Man’s World 31:18

22d ago31:18

31:18

In this episode of The Burn Podcast, we’re joined by trailblazer Molly Fletcher—hailed by CNN as the “female Jerry Maguire.” A former sports agent who represented over 300 elite athletes and coaches, Molly carved her place in a male-dominated industry not by focusing on being the only woman in the room—but by becoming the best in the room. Now a be…

1
Pharma and Biotech Daily: AI Integration, Sanofi Cuts Ties, FDA Delays, and Trump's Drug Pricing Plan 0:45

23d ago0:45

0:45

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA is planning to fully integrate AI into their decision-making process by June 30, with individual centers starting the rollout immediately. Sanofi has cut off its antibody partner, leading to an 80% reduction in h…

1
Death in Kenya: The cover-up that failed a murdered British woman 57:50

25d ago57:50

57:50

When the charred remains of a young British woman were found in the Maasai Mara Game Reserve in 1988, the Kenyan authorities tried to convince her father – and the public – that she had been killed by wild animals. It soon became clear that 28-year-old Julie Ward had been murdered. But no one was ever convicted. This is the story of how the crime w…

1
How tariffs are impacting companies and why activist investors aren’t necessarily villains 58:18

26d ago58:18

58:18

Danni Hewson and Dan Coatsworth go deep into the world of tariffs on this week’s episode of the AJ Bell Money & Markets podcast. They’ll discuss the latest movements, the latest industries in the firing line, and what companies are now saying about the impact of tariffs on earnings and their outlook. [4:20] While it might feel as if the business wo…

1
Pharma and Biotech Daily: Takeda's $30 Billion Investment and Industry Updates 0:47

26d ago0:47

0:47

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Takeda's $30 billion investment in the U.S. is making headlines, along with their opposition to Trump's proposal on drug prices. The FDA's appointment of Vinay Prasad is stirring up mixed reactions within the industry. On …

1
Pharma and Biotech Daily: The Latest in Industry News and Insights 1:57

27d ago1:57

1:57

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo Nordisk predicts a brighter future for Wegovy with the end of the semaglutide shortage, but analysts remain skeptical as Eli Lilly's Zepbound gains ground in sales. The new HHS vaccine requirement has raised question…

1
Lighthouses, Lean, and the Human Factor in Digital Transformation with AstraZeneca’s Jim Fox 24:49

27d ago24:49

24:49

This week’s guest is Jim Fox, SVP of Americas Supply Operations at AstraZeneca. Jim explains how digital manufacturing in pharma has evolved over his nearly 3 decades in the industry, from basic automation and data collection to advanced predictive modeling and integrated digital ecosystems—and why having humans in-the-loop continues to be critical…

1
How to survive and thrive in times of change 34:12

28d ago34:12

34:12

In this episode of SUGTalks, Craig welcomes back Simon Nichols, Founder and CEO of Thrive, for a timely conversation on how to survive and thrive in times of change. Against a backdrop of global uncertainty, they explore why unpredictability affects us so deeply, how different people respond to it, and what role control, mindset, and even denialism…

1
Breaking Down the Latest in Pharma and Biotech: Executive Orders, Investment Trends, and Industry News 0:58

28d ago0:58

0:58

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Donald Trump has issued an executive order to expedite the timeline for building new facilities in the US while increasing inspections on foreign plants. Despite a drop in venture capital fundraising in the firs…

1
How far can we push the boundaries of Digital Twin capabilities? - with Dimitri Mavris from Georgia Tech 20:18

28d ago20:18

20:18

Academic research traditionally focuses on intellectual curiosity and the search for the truth, while corporate research traditionally aims to help companies build and maintain competitive advantages and deliver profit. So how can these two worlds come together for mutual benefit? Dimitri Mavris, Director of the Aerospace Systems Design Laboratory …

1
Navigating CFO Leadership in the Age of AI Growth with Davinder Athwal 52:07

28d ago52:07

52:07

CFO leadership in the age of artificial intelligence and rapid growth is the focus of today's Secrets of Rockstar CFOs episode, where we dive into Davinder Athwal’s journey. In this episode, host Jack McCullough chats with Davinder, who is the Former CFO of Phenom, a groundbreaking AI-powered HR technology company and unicorn based in the Philadelp…

1
Investment Trust Show: how trusts fared in the market sell-off and recovery, opportunities in Asia, and the boring side of tech 1:00:40

29d ago1:00:40

1:00:40

Get the latest on takeovers, wind-downs and manager changes in the world of investment trusts on this month’s special edition of the AJ Bell Money & Markets podcast. [1:25]. Dan Coatsworth chats about which trusts were in demand from AJ Bell customers during the past month’s mark turmoil. [9:15] Martin Gamble reveals which investment trusts were in…

Podcasts Worth a Listen

Astrazeneca Podcasts

Podcasts Worth a Listen